(Q34619054)

3 August 2017

1 reference

title

Laboratory testing for suspected Lyme disease (English)

1 reference

3 August 2017

0 references

Alan G Barbour

0 references

Jonas Bunikis

1 reference

3 August 2017

publication date

1 March 2002

1 reference

Medical Clinics of North America

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

311-340

1 reference

Heterogeneity of Borrelia burgdorferi in the skin

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Laboratory aspects of Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Tickborne infections as a cause of nonspecific febrile illness in Wisconsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Neurocognitive abnormalities in children after classic manifestations of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Cross-reactive proteins of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

New method for detection of Borrelia burgdorferi antigen complexed to antibody in seronegative Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Lyme disease-a tick-borne spirochetosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Development of enzyme-linked immunosorbent assays using recombinant borrelial antigens for serodiagnosis of Borrelia burgdorferi infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Evaluation of the polymerase chain reaction for the detection ofBorrelia burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Antibody Response in Lyme Disease: Evaluation of Diagnostic Tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Demonstration of spirochaetes in patients with Lyme disease with a modified silver stain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

The T-cell proliferative assay in the diagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Western blotting in the serodiagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Differential expression of Borrelia burgdorferi genes during erythema migrans and Lyme arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Introduction to biostatistics: Part 3, Sensitivity, specificity, predictive value, and hypothesis testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Recombinant outer surface protein C ELISA for the diagnosis of early Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Recombinant chimeric Borrelia proteins for diagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi--specific immunoglobulin G, A, and M.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Demonstration of Borrelia burgdorferi infection in a child with Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Evaluation of sera from patients with Lyme disease in the fluorescent treponemal antibody-absorption test for syphilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Prevalence of antibody to Borrelia burgdorferi by indirect fluorescent antibody assay, ELISA, and western immunoblot in healthy adults in Wisconsin and Arizona

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Borrelia lonestari infection after a bite by an Amblyomma americanum tick

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Intralaboratory reliability of serologic and urine testing for Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Persistent parasitemia after acute babesiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Long-term Serological Follow-up of Patients Treated for Chronic Cutaneous Borreliosis or Culture-positive Erythema Migrans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or both.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Serologic diagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Cross-reactivity in serological tests for Lyme disease and other spirochetal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Enzyme-linked immunosorbent assays for Lyme disease: reactivity of subunits of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Physician-diagnosed erythema migrans and erythema migrans-like rashes following Lone Star tick bites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Erythema migrans and early Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Identification of Three Species of Borrelia burgdorferi Sensu Lato (B. burgdorferi Sensu Stricto, B. garinii, and B. afzelii) Among Isolates from Acrodermatitis Chronica Atrophicans Lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Lyme disease update. Current approach to early, disseminated, and late disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Enzyme-Linked Immunosorbent Assay and Indirect Immunofluorescence Assay for Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

In Vitro Inhibition of Borrelia burgdorferi Growth by Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

A Flagella-less Mutant of Borrelia burgdorferi as a Live Attenuated Vaccine in the Murine Model of Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Borrelia burgdorferi-specific immune complexes in acute Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Antibody testing in Lyme disease. A comparison of results in four laboratories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

A relapsing fever group spirochete transmitted by Ixodes scapularis ticks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Summary of the first 100 patients seen at a Lyme disease referral center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Borrelia burgdorferi in joint fluid in chronic Lyme arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Seronegative Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Diagnosis and treatment of Lyme arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

The overdiagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

The Spirochetal Etiology of Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

The Western Immunoblot for Lyme Disease: Determination of Sensitivity, Specificity, and Interpretive Criteria with Use of Commercially Available Performance Panels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Laboratory Evaluation in the Diagnosis of Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Reinfection in erythema migrans disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Use of a novel technique of cutaneous lavage for diagnosis of Lyme disease associated with erythema migrans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

Complement fixation test for the diagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Expert advice and patient expectations: laboratory testing and antibiotics for Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Diagnosis of Lyme borreliosis by an enzyme immunoassay detecting immunoglobulin G reactive to purified Borrelia burgdorferi cell components

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Immunoblot interpretation criteria for serodiagnosis of early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Recommendation to include OspA and OspB in the new immunoblotting criteria for serodiagnosis of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Comparison of different strains of Borrelia burgdorferi sensu lato used as antigens in enzyme-linked immunosorbent assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900089-0

7 January 2021

10.1016/S0025-7125(03)00089-0

Identifiers

DOI

1 reference

3 August 2017

1 reference